Instrument Inactif

Communiqués kneat.com, inc.

Actions

KSI

CA4988241010

Logiciels

Temps Différé Toronto S.E. 22:00:00 12/08/2026			Varia. 5j.	Varia. 1 janv.
6,500 ^CAD	0,00%		0,00%	+32,11%

11/08	Thoma Bravo, L.P. a finalisé l'acquisition de kneat.com, inc. (TSX:KSI).	CI
30/07	Les actionnaires de Kneat.com approuvent l'acquisition par une filiale de Thoma Bravo	MT

Communiqués

11/08	Thoma Bravo Completes Acquisition of Kneat	GL
07/08	Court Grants Final Order Approving Acquisition of Kneat by Thoma Bravo	GL
30/07	Shareholders Overwhelmingly Approve Transaction with Thoma Bravo	GL
13/07	Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Kneat Shareholders Vote “FOR” the Thoma Bravo Transaction	GL
30/06	Kneat Files Management Information Circular in Connection with the Previously Announced Thoma Bravo Transaction	GL
08/06	Kneat Enters into Definitive Agreement to be Acquired by Thoma Bravo in an All-Cash Transaction, Valuing Kneat at Approximately C$650 Million	GL
27/05	Kneat Announces Results of Voting at Annual General Meeting	GL
18/05	Kneat com : Pfizer wins at Kneat Customer Innovation Award VALIDATE 2026	PU
14/05	Kneat com : KSI Q1Fins 2026	PU
14/05	Kneat com : KSI MDA Q1 2026	PU
13/05	Kneat Announces Record Revenue for First Quarter 2026	GL
11/05	Canadian Investment Regulatory Organization Trade Resumption - KSI	AQ
11/05	Kneat.com Responds to Press Report	GL
11/05	Canadian Investment Regulatory Organization Trading Halt - KSI	AQ
30/04	2026 State of Validation Study Reveals Significant Headroom Remains for Further Digitization	GL
28/04	Leading CDMO Selects Kneat to Power Digital Validation Transformation	GL
22/04	Kneat to Announce 2026 First-Quarter Financial Results May 13, 2026	GL
23/03	Kneat com : Q4 2025 AIF	PU
26/02	Kneat com : Shareholders Letter 2025 Year in Review V5	PU
26/02	Kneat com : YEfins Q4 2025	PU
26/02	Kneat com : KSI MD&A Q4 2025	PU
25/02	Kneat Releases 2025 Annual Shareholder Letter Highlighting Resilience, Opportunities Presented by Artificial Intelligence	GL
25/02	Kneat Achieves Record Revenue for Fourth Quarter and Full Year 2025	GL
19/02	Global Pharmaceutical Packaging Manufacturer Selects Kneat	GL
19/02	Global Pharmaceutical Packaging Manufacturer Selects Kneat	AQ